Moolec ScienceMLEC -4.80%46 Days Payable is 321.44 as of Dec. 2025, which is 208% above its 10-year median of 104.29. GuruFocus rates MLEC with a GF Score™ of 46/100 and a GF Value™ of $84.84 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 708 Biotechnology companies, Moolec Science ranks worse than 97.18% on this metric.
The historical rank and industry rank for Moolec Science's Days Payable or its related term are showing as below:
MLEC'
s Days Payable Range Over the Past 10 Years
Min: 1.89 Med: 104.29 Max: 148.21
Current: 8.59
During the past 5 years, Moolec Science's highest Days Payable was 148.21. The lowest was 1.89. And the median was 104.29.
MLEC's Days Payable is ranked worse than 97.18% of 708
companies
in the Biotechnology industry
Industry Median: 113.56
vs MLEC: 8.59
Moolec Science's Days Payable
increased
from Dec. 2024 (0.00) to Dec. 2025 (321.44).
It may suggest that Moolec Sciencedelayed paying its suppliers.
Moolec Science Days Payable Related Terms
Moolec Science Days Payable Historical Data
* Premium members only.
The historical data trend for Moolec Science's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Moolec Science's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moolec Science Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moolec Science's Days Payable distribution charts can be found below:
* The bar in red indicates where Moolec Science's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Moolec Science's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moolec Science (MLEC) has a Days Payable of 321.44 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Moolec Science and its competitors. This is 208% above median its historical median of 104.29. Over the past decade, Moolec Science's Days Payable has ranged from 1.89 to 148.21. According to the industry distribution chart, Moolec Science ranks #688 out of 708 companies in the Biotechnology industry, placing it in the top 97.2%.
Is Moolec Science's Days Payable too high?
Moolec Science's current Days Payable of 321.44 is 208% above median its 10-year median of 104.29. Over the past 10 years, this metric has ranged from a low of 1.89 to a high of 148.21. The Biotechnology industry median Days Payable is 113.56. Moolec Science's value of 321.44 is 183.1% above this industry median. Based on the distribution chart, Moolec Science ranks #688 out of 708 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Moolec Science has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's Days Payable compare to RVPH and CDIO?
According to the Biotechnology industry distribution chart, Moolec Science ranks #688 out of 708 companies for Days Payable. This places Moolec Science in the lower half of its industry. The industry median Days Payable is 113.56. Moolec Science's value of 321.44 is 183.1% above this benchmark. Historically, Moolec Science's own Days Payable has ranged from 1.89 to 148.21 over the past decade. While the company's 10-year median is 104.29 vs. the industry median of 113.56, Moolec Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Moolec Science's current Days Payable of 321.44 is 183.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Moolec Science and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Moolec Science's current Days Payable is 321.44, which is 208% above median its own 10-year median of 104.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $7.62 — trading 91% below its estimated fair value. The current Days Payable is 321.44, which is 208% above median its 10-year median of 104.29 and 183.1% above the Biotechnology industry median of 113.56. Moolec Science's overall GF Score™ is 46/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Moolec Science (MLEC), the current Days Payable is 321.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moolec Science (MLEC) Overvalued in 2026?
Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued.
The current stock price of $7.62 is trading 91% below its estimated GF Value™ of $84.84.
GuruFocus considers Moolec Science to be Possible Value Trap.
Key valuation signals for MLEC:
Days Payable: 321.44 (208% above median its 10-year median of 104.29)
GF Value™: $84.84 vs. price of $7.62 (91% below fair value)
Industry Position: 183.1% above the Biotechnology median (#688 of 708)
No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
46GF Score
Get the complete analysis for MLEC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLEC has been successfully added to your 
